- Novel peripheral histamine H3 receptor antagonist ZPL-868087 attenuates mechanical hypersensitivity in neuropathic pain in mice
E Battell, A C Rosa, P Chazot, R Hiles, A Pini, W Liu, I Obara
- NOVEL PHOTOLABILE NAADP
Raman Parkesh, Sridhar Vasudevan, Alex Berry, Anthony Galione, Grant Churchill
- Novel potent GLUK5 selective kainate receptor antagonists
More JCA, Dolman NP, Alt A, Knauss JL, Collingridge GL, Bleakman D, Jane DE
- Novel shark antibodies engineered to characterise and improve delivery of therapeutics across the blood-brain barrier
A. L. Fleckney1, K. B. Wicher2, P. Stocki2, J. Rutkowski3, S. A. Thomas1. 1Institute of Pharmaceutical Science, King's College London, London, United Kingdom, 2Ossianix INC., Stevenage, United Kingdom, 3Ossianix INC, Philadelphia
- Novel shark antibodies engineered to characterise and improve delivery of therapeutics across the blood-brain barrier
A Fleckney, R Brown, S Drndarski, K Wicher, L Rutkowski, S Thomas
- Novel soluble guanylate cyclase activators as vasodilators: relationship between the degree of enzyme activation and functional efficacy
Edmunds, N.J.; Fairman, D.; Flynn, D.A.; Tones, M.A.
- Novel SRPK1 inhibitors specifically alter alternative splicing and switch VEGF-A expression from pro-angiogenic to anti-angiogenic isoforms.
J Rowlinson, J Morris, D Bates, J Batson
- Novel SRPK1 inhibitors with improved posterior ocular permeability to achieve therapeutic drug levels following topical eye drop administration in wet age-related macular degeneration (wAMD)
J Batson, H Toop, J Rowlinson, Z Blackley, J Morris, D Bates
- Novel strong determinant of hERG channel inhibition on segment S5 (F557)
P Saxena, T Linder, E Timin, S Hering, A Stary-Weinzinger
- Novel synthetic superenhancers for drug screening in cancer stem cells
U. Koeber1,2, S. M. Pollard1,2. 1MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom, 2UK Centre for Mammalian Synthetic Biology, University of Edinburgh, Edinburgh, United Kingdom,
